Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients

Xiao-Fei Zhang, Xin Yang, Hu-Liang Jia, Wen-Wei Zhu, Lu Lu, Wei Shi, Hao Zhang, Jin-Hong Chen, Yi-Feng Tao, Zheng-Xin Wang, Jun Yang, Lian-Xin Wang, Ming Lu, Yan Zheng, Jing Zhao, Qiong-Zhu Dong,, Lun-Xiu Qin,Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 00040, China;Cancer Research Center, Institutes of Biomedical Science, Fudan University, Shanghai 000, China;Department of General Surgery, Qidong Hospital, Qidong 600, China

In the published article1, errors appeared in the figure legend on page 462. The corrected figure legend is reproduced here.

Figure 1 Different expression status of Bcl-2 in tumor tissues detected by immunohistochemical staining and its correlation with the prognosis of HCC patients. (A) The graph was from a strong positive case in Bcl-2 expression. (B) The graph shows a weakly positive expression level. (C) The graph was a totally negative one that showed little staining of Bcl-2. Positive cells were stained brown (100×); Bar=100 μm. (D) High Bcl-2 density in tumor was associated with prolonged OS and TTR. (E) Different expression status of Bcl-2 in tumor tissues detected by immunohistochemical staining and its correlation with the prognosis of HCC patients.

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients

Xiao-Fei Zhang1, Xin Yang1, Hu-Liang Jia1, Wen-Wei Zhu1, Lu Lu1, Wei Shi1, Hao Zhang1, Jin-Hong Chen1, Yi-Feng Tao1, Zheng-Xin Wang1, Jun Yang3, Lian-Xin Wang3, Ming Lu1, Yan Zheng1, Jing Zhao1, Qiong-Zhu Dong1,2, Lun-Xiu Qin1,21Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai 200040, China;2Cancer Research Center, Institutes of Biomedical Science, Fudan University, Shanghai 200032, China;3Department of General Surgery, Qidong Hospital, Qidong 226200, China

In the published article1, errors appeared in the figure legend on page 462. The corrected figure legend is reproduced here.

Figure 1 Different expression status of Bcl-2 in tumor tissues detected by immunohistochemical staining and its correlation with the prognosis of HCC patients. (A) The graph was from a strong positive case in Bcl-2 expression. (B) The graph shows a weakly positive expression level. (C) The graph was a totally negative one that showed little staining of Bcl-2. Positive cells were stained brown (100×); Bar=100 μm. (D) High Bcl-2 density in tumor was associated with prolonged OS and TTR. (E) Different expression status of Bcl-2 in tumor tissues detected by immunohistochemical staining and its correlation with the prognosis of HCC patients.

The authors and editors apologize for the errors and for any confusion it may have caused.

10.20892/j.issn.2095-3941.2017.0011

Lun-Xiu Qin

E-mail: qin_lx@yahoo.com

Received February 13, 2017; accepted February 14, 2017. Available at www.cancerbiomed.org

Copyright ? 2017 by Cancer Biology & Medicine

1.Zhang X, Yang X, Jia H, Zhu W, Lu L, Shi W, et al. Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients. Cancer Biol Med. 2016; 13: 459-68.

Cite this article as:Zhang X, Yang X, Jia H, Zhu W, Lu L, Shi W, et al. Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients. Cancer Biol Med. 2017; 14: 108.